FDA Inspection 1222586 — Jharkhand Cancer Centre (A Unit Of Shambhavi Centre For Cancer And Gynaecology Pvt. Ltd.)
The FDA completed an inspection of Jharkhand Cancer Centre (A Unit Of Shambhavi Centre For Cancer And Gynaecology Pvt. Ltd.) on Oct 20, 2023 in Ranchi. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 20, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ranchi (India)
Additional Details
Clinical BA/BE